Orbitofrontal Cortex Functional Connectivity-Based Classification for Chronic Insomnia Disorder Patients With
Liang Gong1, Ronghua Xu1, Dan Yang1
1Department of Neurology, Chengdu Second People's Hospital, Chengdu, China.
Frontiers in Psychiatry
|July 25, 2022
Summary
Machine learning identified orbital frontal cortex (OFC) functional connectivity patterns to distinguish chronic insomnia disorder (CID) patients with and without depression. This offers a potential biomarker for early diagnosis and intervention in comorbid cases.
Area of Science:
- Neuroscience
- Psychiatry
- Machine Learning
Background:
- Depression frequently co-occurs with chronic insomnia disorder (CID).
- The orbital frontal cortex (OFC) is implicated as a key brain region linking insomnia and depression.
- Neuroimaging studies suggest altered OFC function in comorbid conditions.
Purpose of the Study:
- To develop a machine learning model to differentiate CID patients with and without depressive symptoms.
- To investigate the role of OFC functional connectivity (FC) as a potential biomarker for comorbid depression in CID.
- To validate the predictive accuracy of the OFC FC-based model in an independent cohort.
Main Methods:
- Seventy CID patients were classified into high (CID-HD) and low (CID-LD) depressive symptom groups.
- OFC functional connectivity (FC) networks were constructed using the OFC as a seed region.
- A linear kernel Support Vector Machine (SVM) model was trained and tested for classification accuracy.
Main Results:
- The OFC FC-based model achieved 76.92% accuracy in classifying CID-HD and CID-LD groups (p = 0.0009).
- The model's area under the receiver operating characteristic curve was 0.84.
- Key predictive features included OFC connectivity with reward, salience, and default mode networks.
- Validation in an independent cohort yielded 67.9% accuracy.
Conclusions:
- OFC functional connectivity patterns can differentiate CID patients with and without depressive symptoms.
- An OFC FC-based machine learning approach shows potential as a biomarker for early diagnosis and intervention.
- This method may aid in managing comorbid depression in chronic insomnia disorder.
Related Concept Videos
Insomnia
121
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
121
Management of Insomnia
316
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
316
Depressive Disorders: MDD and Dysthymia
202
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
202
Depressive Disorders: Etiology
162
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
162
Depression: Overview
327
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
327
Substance Use Disorders Affecting Sleep
213
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
213


